Use of Integrated Pulmonary Index Monitorisation in Children Undergoing Botulinum Toxin Injection
NCT ID: NCT05724030
Last Updated: 2024-10-15
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
69 participants
INTERVENTIONAL
2023-04-03
2024-10-11
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Intermittent Versus Continuous Pulse Oximetry Monitoring of Infants Admitted for Bronchiolitis
NCT01014910
Importance of Integrated Pulmonary Index in Pediatric Bronchoscopy
NCT05137587
Integrated Pulmonary Index (IPI) as a Determinate of Weaning Success and/or Failure in the Pediatric Population
NCT01795196
Utility of Continuous Pulse Oximetry for Pediatric Patients With Stable Respiratory Illness
NCT04407806
The Evaluation of a Noninvasive Respiratory Monitor in Pediatric Patients Undergoing General Anesthesia
NCT02336022
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
CROSSOVER
DIAGNOSTIC
SINGLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
integrated pulmonary index hypoxia -capnogarph
integrated pulmonary index montorization apliied
integrated pulmonary index
integarted pumobary index monitoring
saturation
saturation monitorization
saturation - apnea
saturation apllied
integrated pulmonary index
integarted pumobary index monitoring
saturation
saturation monitorization
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
integrated pulmonary index
integarted pumobary index monitoring
saturation
saturation monitorization
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* undergoing botilinum injection with sedation
* asa 1-2
Exclusion Criteria
* asa 3-4
* patients with upper respiratory tract infection
4 Years
16 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Kocaeli University
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Zehra Ipek ARSLAN
Professor
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Kocaeli University School of Medicine
Kocaeli, , Turkey (Türkiye)
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
KAEK/26.bl.06
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.